Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Lieberman, R' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 97 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Brekke, MK; Lieberman, R; Wright, E; Green, DR
      Posterior facet talocalcaneal coalition

      JOURNAL OF THE AMERICAN PODIATRIC MEDICAL ASSOCIATION
    2. Liu, YQ; Kyle, E; Patel, S; Housseau, F; Hakim, F; Lieberman, R; Pins, M; Blagosklonny, MV; Bergan, RC
      Prostate cancer chemoprevention agents exhibit selective activity against early stage prostate cancer cells

      PROSTATE CANCER AND PROSTATIC DISEASES
    3. Geske, FJ; Lieberman, R; Strange, R; Gerschenson, LE
      Early stages of p53-induced apoptosis are reversible

      CELL DEATH AND DIFFERENTIATION
    4. Menter, DG; Hoque, A; Motiwala, N; Sahin, AA; Sneige, N; Lieberman, R; Lippman, SM
      Computerized image analysis of Ki-67 in ductal breast carcinoma in situ

      ANALYTICAL AND QUANTITATIVE CYTOLOGY AND HISTOLOGY
    5. Carroll, PR; Fair, WR; Grossfeld, GD; Heston, WDW; Lieberman, R; Malkowicz, SB; Stricker, HJ; Sylvester, J; Peehl, DM; Meyer, F; Hart, C
      Overview consensus statement

      UROLOGY
    6. Fair, WR; Stricker, HJ; Lieberman, R; Bubley, GJ; Trachtenberg, J; Heston, WDW
      Discussion following Dr. Hans J. Stricker's presentations

      UROLOGY
    7. Lieberman, R; Gleave, ME; Carroll, PR; Bubley, GJ
      Discussion following Dr. Martin E. Gleave's presentation

      UROLOGY
    8. Lieberman, R
      Androgen deprivation therapy for prostate cancer chemoprevention: Current status and future directions for agent development

      UROLOGY
    9. Lieberman, R; Lubeck, DP; Trachtenberg, J; Stricker, HJ; Newling, DWW; Fair, WR; Carroll, PR
      The effect of androgen deprivation therapy on health-related quality of life in men with prostate cancer - Discussion

      UROLOGY
    10. Newling, DWW; Daniell, HW; Lieberman, R; Sylvester, J; Trachtenberg, J
      Osteoporosis due to androgen deprivation therapy in men with prostate cancer - Discussion

      UROLOGY
    11. Lieberman, R; Nelson, WG
      New clinical trial strategies for prostate cancer prevention - Introduction

      UROLOGY
    12. Lieberman, R; Nelson, WG; Sakr, WA; Meysken, FL; Klein, EA; Wilding, G; Partin, AW; Lee, JJ; Lippman, SM
      Executive summary of the National Cancer Institute Workshop: Highlights and recommendations

      UROLOGY
    13. Kelloff, GJ; Lieberman, R; Seele, VE; Boone, CM; Lubet, RA; Kopelovich, L; Malone, WA; Crowell, JA; Higley, HR; Sigman, CC
      Acents, biomarkers, and cohorts for chemopreventive agent development in prostate cancer

      UROLOGY
    14. Boone, CW; Lieberman, R; Mairinger, T; Palcic, B; Bacus, J; Bartels, P
      Computer-assisted image analysis-derived intermediate endpoints

      UROLOGY
    15. Lopacznski, W; Hruszkewycz, AM; Lieberman, R
      Preprostatectomy: A clinical model to study stromal-epithelial interactions

      UROLOGY
    16. Lee, JD; Lieberman, R; Sloan, JA; Piantadosi, S; Lippman, SM
      Design considerations for efficient prostate cancer chemoprevention trials

      UROLOGY
    17. Weiss, HL; Urban, DA; Grizzle, WE; Cronin, KA; Freedman, LS; Kelloff, GJ; Lieberman, R
      Bayesian monitoring of a phase 2 chemoprevention trial in high-risk cohorts for prostate cancer

      UROLOGY
    18. Lieberman, R
      Prostate cancer chemoprevention: Strategies for designing efficient clinical trials

      UROLOGY
    19. Lieberman, R
      Chemoprevention of superficial bladder cancer

      CANCER CHEMOPREVENTION
    20. Greenwald, P; Lieberman, R
      Chemoprevention trials for prostate cancer

      PROSTATE CANCER
    21. Lieberman, R
      HIV in older Americans: An epidemiologic perspective

      JOURNAL OF MIDWIFERY & WOMENS HEALTH
    22. Geske, FJ; Nelson, AC; Lieberman, R; Strange, R; Sun, T; Gerschenson, LE
      DNA repair is activated in early stages of p53-induced apoptosis

      CELL DEATH AND DIFFERENTIATION
    23. Singletary, E; Lieberman, R; Atkinson, N; Sneige, N; Sahin, A; Tolley, S; Colchin, M; Bevers, T; Stelling, C; Fornage, B; Fritsche, H; Hittelman, W; Kelloff, G; Lippman, SM
      Novel translational model for breast cancer chemoprevention study: Accrualto a presurgical intervention with tamoxifen and N-[4-hydroxyphenyl] retinamide

      CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
    24. Liu, YQ; Kyle, E; Lieberman, R; Crowell, J; Kelloff, G; Bergan, RC
      Focal adhesion kinase (FAK) phosphorylation is not required for genistein-induced FAK-beta-1-integrin complex formation

      CLINICAL & EXPERIMENTAL METASTASIS
    25. Kelloff, GJ; Crowell, JA; Steele, VE; Lubet, RA; Malone, WA; Boone, CW; Kopelovich, L; Hawk, ET; Lieberman, R; Lawrence, JA; Ali, I; Viner, JL; Sigman, CC
      Progress in cancer chemoprevention: Development of diet-derived chemopreventive agents

      JOURNAL OF NUTRITION
    26. Lieberman, R
      Raising reds: The young pioneers, radical summer camps, and communist political culture in the United States.

      JOURNAL OF AMERICAN HISTORY
    27. Lieberman, R
      Red diapers: Growing up in the communist left.

      JOURNAL OF AMERICAN HISTORY
    28. Lieberman, R
      Democratic artworks: Politics and the arts from Trilling to Dylan.

      AMERICAN HISTORICAL REVIEW
    29. Kelloff, GJ; Lieberman, R; Brawer, MK; Crawford, ED; Labrie, F; Miller, GJ
      Strategies for chemoprevention of prostate cancer

      PROSTATE CANCER AND PROSTATIC DISEASES
    30. Cronin, KA; Freedman, LS; Lieberman, R; Weiss, HL; Beenken, SW; Kelloff, GJ
      Bayesian monitoring of Phase II trials in cancer chemoprevention

      JOURNAL OF CLINICAL EPIDEMIOLOGY
    31. Cronin, KA; Freedman, LS; Lieberman, R
      Reply to the dissent by Hans C. van Houwelingen

      JOURNAL OF CLINICAL EPIDEMIOLOGY
    32. Kelloff, GJ; Lieberman, R; Steele, VE; Boone, CW; Lubet, RA; Kopelovitch, L; Malone, WA; Crowell, JA; Sigman, CC
      Chemoprevention of prostate cancer: Concepts and strategies

      EUROPEAN UROLOGY
    33. Urban, D; Myers, R; Manne, U; Weiss, H; Mohler, J; Perkins, D; Markiewicz, M; Lieberman, R; Kelloff, G; Marshall, M; Grizzle, W
      Evaluation of biomarker modulation by fenretinide in prostate cancer patients

      EUROPEAN UROLOGY
    34. Shaw, LM; Bonner, HS; Schuchter, L; Schiller, J; Lieberman, R
      Pharmacokinetics of amifostine: Effects of dose and method of administration

      SEMINARS IN ONCOLOGY
    35. Lieberman, R; O'Connor, DM; Henry, MR
      Colposcopy in pregnancy: Directed brush cytology compared with cervical biopsy - Reply

      OBSTETRICS AND GYNECOLOGY
    36. Lieberman, R
      The death and rebirth of American radicalism

      HISTORIAN
    37. KELLOFF GJ; LUBET RA; LIEBERMAN R; EISENHAUER K; STEELE VE; CROWELL JA; HAWK ET; BOONE CW; SIGMAN CC
      AROMATASE INHIBITORS AS POTENTIAL CANCER CHEMOPREVENTIVES

      Cancer epidemiology, biomarkers & prevention
    38. GESKE FJ; NELSON AC; LIEBERMAN R; STRANGE R; GERSCHENSON LE
      DNA-REPAIR REGULATES EARLY STAGES OF P53-INDUCED APOPTOSIS

      The FASEB journal
    39. BERGAN R; PATEL S; KYLE E; VISHNUVAJJALA B; LIEBERMAN R
      PK-PD OF PERILLYL ALCOHOL (PAL) AND METABOLITES (METAB) IN A HUMAN PROSTATE-CANCER (PCA) MODEL SYSTEM - IMPLICATIONS FOR TDM IN CANCER

      Clinical pharmacology and therapeutics
    40. LIEBERMAN R; CROWELL JA; HAWK ET; BOONE CW; SIGMAN CC; KELLOFF GJ
      DEVELOPMENT OF NEW CANCER CHEMOPREVENTION AGENTS - ROLE IN PHARMACOKINETIC PHARMACODYNAMIC AND INTERMEDIATE END-POINT BIOMARKER MONITORING/

      Clinical chemistry
    41. LIEBERMAN R
      OLD LIGHT IN AN OLD WORK + DONATELLO 'ANNUNCIATION', QUATTROCENTO SCULPTURE

      Source
    42. TAKIMOTO CH; DAHUT W; MARINO MT; NAKASHIMA H; LIANG MD; HAROLD N; LIEBERMAN R; ARBUCK SG; BAND RA; CHEN AP; HAMILTON JM; CANTILENA LR; ALLEGRA CJ; GREM JL
      PHARMACODYNAMICS AND PHARMACOKINETICS OF A 72-HOUR INFUSION OF 9-AMINOCAMPTOTHECIN IN ADULT CANCER-PATIENTS

      Journal of clinical oncology
    43. BOYER D; CANTRILL H; JAFFE G; KUPPERMANN B; LALEZARI J; LAMBERT M; LIEBERMAN R; PARK S; TERRY B
      RELATIVE RISK ASSESSMENT OF RETINAL-DETACHMENT OR ENDOPHTHALMITIS WITH INTRAVITREAL INJECTIONS OF EYES WITH CMV RETINITIS

      Investigative ophthalmology & visual science
    44. MANSOUR S; KUPPERMANN B; LAMBERT M; DUKER J; LIEBERMAN R
      CASE-STUDIES OF INTRAVITREAL FOMIVIRSEN SODIUM FOR CMV RETINITIS UNRESPONSIVE TO CIDOFOVIR

      Investigative ophthalmology & visual science
    45. LIEBERMAN R; ANTOSZYK A; BOYER D; DANIS R; DUKER J; FISH R; GOLDSTEIN D; JOHNSON D; KUPPERMANN B; LAMBERT M; MANSOUR S; PALESTINE A; PARK S; TERRY B; VRABEC T
      ANTISENSE OLIGONUCLEOTIDE (FOMIVIRSEN SODIUM) TREATMENT OF CMV RETINITIS UNRESPONSIVE TO OTHER ANTIVIRAL THERAPIES

      Investigative ophthalmology & visual science
    46. SINGH M; KARACEK J; LIEBERMAN R; HUFF JC; NORRIS DA; GERSCHENSON LE
      BASAL-CELL CARCINOMAS ARE MORE SUSCEPTIBLE THAN NORMAL HUMAN EPIDERMIS TO THE INDUCTION OF APOPTOSIS OR NECROSIS BY METABOLIC-INHIBITORS

      Journal of investigative dermatology
    47. LIEBERMAN R
      WHEN WE WERE GOOD - THE FOLK REVIVAL - CANTWELL,R

      The Journal of American history
    48. LIEBERMAN R; BOONE C; CROWELL J; HAWK E; MALONE W; STEELE V; LUBET R; SIGMAN C; KELLOFF G
      SURROGATE END-POINT BIOMARKER (SEB) GUIDED DRUG DEVELOPMENT - A PRACTICAL STRATEGY FOR CHEMOPREVENTION (CP) OF PREINVASIVE CANCER (PRECA)

      Clinical pharmacology and therapeutics
    49. LIEBERMAN R
      THE GREAT-DEPRESSION AND THE CULTURE OF ABUNDANCE - FEARING,KENNETH, WEST,NATHANAEL, AND MASS-CULTURE IN THE 1930S - BARNARD,R

      The American historical review
    50. CALKINS H; PRYSTOWSKY E; BERGER RD; SAUL JP; KLEIN LS; LIEM LB; HUANG SKS; GILLETTE P; YONG P; CARLSON M; KAY GN; DAILEY S; EPSTEIN A; PLUMB V; WHARTON JM; KANTER R; SORRENTINO R; GREENFIELD RA; WALSH E; WALDO A; BIBLO L; JOHNSON N; LIEBERMAN R; ROSENBAUM D; MACKALL J; VANHARE G; MITTLEMAN RS; WAGSHAL AB; GREENE T; LAUER M; SUNG R; YOUNG C; EVANS J; HACKETT K; MILES W; ZIPES D; SWARTZ J; LAWRENCE J; TOMASELLI G
      RECURRENCE OF CONDUCTION FOLLOWING RADIOFREQUENCY CATHETER ABLATION PROCEDURES - RELATIONSHIP TO ABLATION TARGET AND ELECTRODE TEMPERATURE

      Journal of cardiovascular electrophysiology
    51. DAHUT W; HAROLD N; TAKIMOTO C; ALLEGRA C; CHEN A; HAMILTON JM; ARBUCK S; SORENSEN M; GROLLMAN F; NAKASHIMA H; LIEBERMAN R; LIANG M; CORSE W; GREM J
      PHASE-I AND PHARMACOLOGICAL STUDY OF 9-AMINOCAMPTOTHECIN GIVEN BY 72-HOUR INFUSION IN ADULT CANCER-PATIENTS

      Journal of clinical oncology
    52. LIEBERMAN R; MCMICHAEL J
      ROLE OF PHARMACOKINETIC-PHARMACODYNAMIC PRINCIPLES IN RATIONAL AND COST-EFFECTIVE DRUG DEVELOPMENT

      Therapeutic drug monitoring
    53. MCMICHAEL J; LIEBERMAN R; MCCAULEY J; IRISH W; MARINO I; DOYLE H
      COMPUTER-GUIDED RANDOMIZED CONCENTRATION-CONTROLLED TRIALS OF TACROLIMUS IN AUTOIMMUNITY - MULTIPLE-SCLEROSIS AND PRIMARY BILIARY-CIRRHOSIS

      Therapeutic drug monitoring
    54. SHAW LM; BONNER H; LIEBERMAN R
      PHARMACOKINETIC PROFILE OF AMIFOSTINE

      Seminars in oncology
    55. GOLDMAN SA; LIEBERMAN R; KAUSAL DJ
      TEACHING HEALTH-CARE PROFESSIONALS ABOUT DRUG-INDUCED DISEASE - AN INNOVATIVE CLINICAL THERAPEUTIC APPROACH

      Journal of clinical pharmacology
    56. MCMICHAEL J; LIEBERMAN R; MCCAULEY J; IRISH W; DOYLE H
      CONCENTRATION CONTROLLED TRIALS (CCT) OF TACROLIMUS (TAC) IN AUTOIMMUNITY (AL), PK-PD CORRELATIONS

      Clinical pharmacology and therapeutics
    57. NAKASHIMA H; LIEBERMAN R; KARATO A; SAIJO N
      BAYESIAN-ESTIMATION FOR TDM OF ANTICANCER DRUGS - EVALUATION OF DIFFERENT POPULATION METHODS

      Clinical pharmacology and therapeutics
    58. HAUSFELD AD; LIEBERMAN R; RODIONOVA NA; LAWS WR
      PURIFICATION OF MEMBRANE-PROTEINS BY NON-AMPHOLYTE ISOELECTRIC-FOCUSING - APPLICATION TO CYTOCHROME B(5) AND NADPH CYTOCHROME-P450 REDUCTASE

      Biophysical journal
    59. GESKE FJ; LIEBERMAN R; STRANGE R; GERSCHENSON LE
      EVIDENCE FOR DNA-REPAIR IN CYCLOHEXIMIDE-INDUCED APOPTOSIS USING HUMAN AND MOUSE-CELL LINES

      The FASEB journal
    60. JUSKO WJ; THOMSON AW; FUNG J; MCMASTER P; WONG SH; ZYLBERKATZ E; CHRISTIANS U; WINKLER M; FITZSIMONS WE; LIEBERMAN R; MCBRIDE J; KOBAYASHI M; WARTY V; SOLDIN SJ
      CONSENSUS DOCUMENT - THERAPEUTIC MONITORING OF TACROLIMUS (FK-506)

      Therapeutic drug monitoring
    61. SHAW LM; SOLLINGER HW; HALLORAN P; MORRIS RE; YATSCOFF RW; RANSOM J; TSINA I; KEOWN P; HOLT DW; LIEBERMAN R; JAKLITSCH A; POTTER J
      MYCOPHENOLATE MOFETIL - A REPORT OF THE CONSENSUS PANEL

      Therapeutic drug monitoring
    62. NAKASHIMA H; LIEBERMAN R; KARATO A; ARIOKA H; OHMATSU H; NOMURA N; SHIRAISHI J; TAMURA T; EGUCHI K; SHINKAI T; SASAKI Y; YAMAMOTO N; HUKUDA M; OSHITA F; OHE Y; SAIJO N
      EFFICIENT SAMPLING STRATEGIES FOR FORECASTING PHARMACOKINETIC PARAMETERS OF IRINOTECAN (CPT-11) - IMPLICATION FOR AREA UNDER THE CONCENTRATION-TIME CURVE MONITORING

      Therapeutic drug monitoring
    63. PALESTINE AG; CANTRILL H; AI E; LIEBERMAN R
      TREATMENT OF CYTOMEGALOVIRUS (CMV) RETINITIS WITH ISIS-2922

      Investigative ophthalmology & visual science
    64. NAKASHIMA H; LIEBERMAN R; KARATO A; SAIJO N
      BAYESIAN-ESTIMATION (BE) AND LIMITED SAMPLING METHODS (LSM) ARE COST-EFFECTIVE (CE) MONITORING STRATEGIES FOR ANTICANCER DRUGS (ACD)

      Clinical pharmacology and therapeutics
    65. LIEBERMAN R
      THE BEAUTY TRIP - SIMAN,K

      Artforum
    66. LIEBERMAN R
      SURVIVAL OF THE FITTED - FASHION WEEK IN NEW-YORK

      Artforum
    67. LIEBERMAN R
      GOYS AND DOLLS - THE FURTHER ADVENTURES OF JEWISH BARBIE

      Artforum
    68. LIEBERMAN R
      JE-MAPPELLE-BARBIE - THE OTHER AMERICAN PRINCESS, THE JEWISH BARBIE

      Artforum
    69. LIEBERMAN R
      SWEDISH WINTER - SHE-DEVILS THE MOVIE (1989)

      Artforum
    70. LIEBERMAN R
      SPRINGS ETERNAL + BRAND-NAME SUPER-MODEL

      Artforum
    71. LIEBERMAN R
      BETWEEN FRIENDS - THE CORRESPONDENCE OF ARENDT,HANNAH AND MCCARTHY,MARY, 1949-1975 - ARENDT,H, MCCARTHY,M, BRIGHTMAN,C

      Artforum
    72. LIEBERMAN R
      RHYTHM AND RESISTANCE - EXPLORATIONS IN THE POLITICAL USES OF POPULAR-MUSIC - PRATT,R

      American music
    73. LIEBERMAN R
      BORN IN THE USA - THE MYTH OF AMERICA IN POPULAR-MUSIC FROM COLONIAL TIMES TO THE PRESENT - SCHEURER,TE

      American music
    74. MUKHERJEE A; LE K; LIEBERMAN R
      RELEVANCE OF PRECLINICAL PK-PD TO THE CLINICAL IMMUNOMODULATORY (IMMOD) EFFECTS OF FK-506 IN TRANSPLANTATION (TX) AND AUTOIMMUNITY (AL)

      Clinical pharmacology and therapeutics
    75. CALKINS H; PRYSTOWSKY E; CARLSON M; KLEIN LS; SAUL JP; KAY GN; DAILEY S; EPSTEIN A; PLUMB V; WHARTON M; KANTER R; SORRENTINO R; GREENFIELD RA; WALSH E; WALDO A; BIBLO L; JOHNSON N; LIEBERMAN R; ROSENBAUM D; HUANG SKS; MITTLEMAN RS; WAGSHAL AB; GREENE T; LIEM B; LAUER M; SUNG R; YOUNG C; EVANS J; CASE C; HACKETT K; MILES W; ZIPES D; LAWRENCE J; TOMASELLI G; BERGER R
      TEMPERATURE MONITORING DURING RADIOFREQUENCY CATHETER ABLATION PROCEDURES USING CLOSED-LOOP CONTROL

      Circulation
    76. LIEBERMAN R
      SMALL TALK + TV TALK SHOW HOSTS

      Artforum
    77. LIEBERMAN R
      CAN WE TALK - TV MOVIES

      Artforum
    78. LIEBERMAN R
      DISTRESSED GLAMOUR AS FASHION TREND

      Artforum
    79. LIEBERMAN R
      THE GENX READER - RUSHKOFF,D

      Artforum
    80. LIEBERMAN R
      POSITIVELY CAMP - THE HIRSH-FARM PROJECT

      Artforum
    81. LIEBERMAN R
      ZEN AND THE ART OF SHOPPING + NEWTON,HELMUT PHOTOGRAPHS

      Artforum
    82. RIMANELLI D; WATERS J; LIEBERMAN R
      GORE-GIRL - WATERS,JOHN TALKS ABOUT HIS NEW MOVIE 'SERIAL MOM'

      Artforum
    83. LIEBERMAN R
      REVENGE OF THE MOUSE DIVA + THE ART OF KILIMNIK,KAREN

      Artforum
    84. LIEBERMAN R
      FEAR AND FLOATING IN VIENNA - THE INDISCREET CHARM OF BERNHARD,THOMAS

      Artforum
    85. LIEBERMAN R
      ELGORT,ARTHUR MODELS MANUAL - ELGORT,A

      Artforum
    86. LIEBERMAN R
      PHILOSOPHERS - PYKE,S

      Artforum
    87. SHAW LM; BONNER HS; FIELDS L; LIEBERMAN R
      THE USE OF CONCENTRATION MEASUREMENTS OF PARENT DRUG AND METABOLITES DURING CLINICAL-TRIALS

      Therapeutic drug monitoring
    88. LIEBERMAN R; NELSON R
      DOSE-RESPONSE AND CONCENTRATION RESPONSE RELATIONSHIPS - CLINICAL ANDREGULATORY PERSPECTIVES

      Therapeutic drug monitoring
    89. MCMICHAEL J; LIEBERMAN R; DOYLE H; MCCAULEY J; VANTHIEL D; THOMSON A; FUNG J; STARZL TE
      COMPUTER-GUIDED CONCENTRATION-CONTROLLED TRIALS IN AUTOIMMUNE DISORDERS

      Therapeutic drug monitoring
    90. LIEBERMAN R
      FK506, ARTIFICIAL-INTELLIGENCE AND PHARMACOECONOMICS

      Journal of clinical pharmacology
    91. MCMICHAEL J; LIEBERMAN R; DOYLE H; MCCAULEY J; FUNG J; STARZL TE
      AN INTELLIGENT AND COST-EFFECTIVE COMPUTER DOSING SYSTEM FOR INDIVIDUALIZING FK506 THERAPY IN TRANSPLANTATION AND AUTOIMMUNE DISORDERS

      Journal of clinical pharmacology
    92. BLANCHARD RL; LIEBERMAN R; RICHARDSON WS; WAKAMO CL
      CONSIDERATIONS OF ACIDIFYING WATER SAMPLES FOR TC-99 ANALYSIS

      Health physics
    93. LIEBERMAN R; LEIBOWITZ CS; SAUL P
      ITS BEEN NICE GNAWING YOU - A CONVERSATION WITH SAUL,PETER

      Artforum
    94. LIEBERMAN R
      CONFESSIONS OF ANOTHER PRETTY LADY + COMMENTS ON BERNHARD,SANDRA

      Artforum
    95. LIEBERMAN R
      BOROFSKY,JONATHAN 'WHAT IS DRAGGING ME'

      Artforum
    96. LIEBERMAN R
      SPRINGTIME FOR GRUNGE + THE NEW POWER SCHLUB

      Artforum
    97. LIEBERMAN R
      GLAMOUR WOUNDS - WE TRY HARDER( MINNELLI,LIZA )

      Artforum


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 01/06/20 alle ore 22:57:00